Biosimilars

Latest News

Biosimilar Introduction Reduces Biologic Price in US and Globally
Biosimilar Introduction Reduces Biologic Prices in the US and Globally

June 13th 2024

After a biosimilar introduction, the prices of the biologic products—namely, trastuzumab, infliximab, bevacizumab, adalimumab, filgrastim, and pegfilgrastim—were significantly reduced.

| Image Credit: Twitter
Switch to Anti-TNF Biosimilar Well-Tolerated in Juvenile Idiopathic Arthritis

June 11th 2024

Biosimilars Council Encourages FDA to Streamline the Development of Biosimilars
Biosimilars Council Encourages FDA to Streamline the Development of Biosimilars

June 6th 2024

Biosimilars Month in Review: May 2024
Biosimilars Month in Review: May 2024

June 6th 2024

1 out of 3 Patients with PsA/PsO Switch, Swap Biologics Within 3 Years
1 out of 3 Patients with PsA/PsO Switch, Swap Biologics Within 3 Years

June 3rd 2024

© 2024 MJH Life Sciences

All rights reserved.